Cholesterol and Screening of Asymptomatic Adults
Authors: Matthew F. Muldoon
Journal: Annals of Internal Medicine (1990)

Letters and Corrections1 March 1990Cholesterol and Screening of Asymptomatic AdultsMatthew F. Muldoon, MDMatthew F. Muldoon, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-112-5-384 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the Editor:I read with great interest the article by Dr. Garber and colleagues (1) on the role of cholesterol screening in asymptomatic adults. On the advice of the National Cholesterol Education Program, the entire nation has embarked on a crusade to lower serum cholesterol. Recently, however, several heated debates have erupted regarding the scientific basis of these recommendations. Consequently, I was eager to read the Stanford group's assessment of the literature and hoped that their review might clarify controversies attributable to conflicting interpretations of existing data. Instead, I found that Dr. Garber and colleagues may have misled the...References1. GarberSoxLittenberg AHB. Screening asymptomatic adults for cardiac risk factors: the serum cholesterol level. Ann Intern Med. 1989;110:622-39. LinkGoogle Scholar2. . The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in the incidence of coronary heart disease. JAMA. 1984;251:351-64. CrossrefMedlineGoogle Scholar3. HjermannVelve ByreHolmeLeren IKIP. Effect of diet and smoking intervention on the incidence of coronary heart disease: report from the Oslo Study Group of a randomized trial in healthy men. Lancet. 1981;2:1303-10. CrossrefMedlineGoogle Scholar1. GarberSoxLittenberg AHB. Screening asymptomatic adults for cardiac risk factors: the serum cholesterol level. Ann Intern Med. 1989;110:622-39. LinkGoogle Scholar2. Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in the incidence of coronary heart disease. JAMA. 1984;251:351-64. CrossrefMedlineGoogle Scholar3. YusufCutler SJ. Single factor trials: drug studies. In: Olsson AG, ed. Atherosclerosis: Biology and Clinical Science. New York: Churchill Livingstone; 1987:393-8. Google Scholar4. DaytonPearceHashimotoDixonTomiyasu SMSWU. A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation. 1969;40(Suppl II):1-63. MedlineGoogle Scholar5. HebertFiebachEberleinTaylorHennekens PNKJC. The community-based randomized trials of pharmacologic treatment of mild-to-moderate hypertension. Am J Epidemiol. 1988;127:581-90. CrossrefMedlineGoogle Scholar6. CannerBergeWenger PKN Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol. 1986;8:1245-55. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 March 1990Volume 112, Issue 5Page: 384-385KeywordsCholesterol Issue Published: 1 March 1990 PDF DownloadLoading ...